BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31842455)

  • 1. The Mechanism of Bisphenol A Atherogenicity Involves Apolipoprotein A-I Downregulation through NF-κB Activation.
    Trusca VG; Dumitrescu M; Fenyo IM; Tudorache IF; Simionescu M; Gafencu AV
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model.
    Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
    Moore RE; Kawashiri MA; Kitajima K; Secreto A; Millar JS; Pratico D; Rader DJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1914-20. PubMed ID: 12933536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic exposure to bisphenol A can accelerate atherosclerosis in high-fat-fed apolipoprotein E knockout mice.
    Kim MJ; Moon MK; Kang GH; Lee KJ; Choi SH; Lim S; Oh BC; Park DJ; Park KS; Jang HC; Park YJ
    Cardiovasc Toxicol; 2014 Jun; 14(2):120-8. PubMed ID: 24234673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.
    Wilhelm AJ; Zabalawi M; Grayson JM; Weant AE; Major AS; Owen J; Bharadwaj M; Walzem R; Chan L; Oka K; Thomas MJ; Sorci-Thomas MG
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):843-9. PubMed ID: 19286630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.
    Zabalawi M; Bhat S; Loughlin T; Thomas MJ; Alexander E; Cline M; Bullock B; Willingham M; Sorci-Thomas MG
    Am J Pathol; 2003 Sep; 163(3):1201-13. PubMed ID: 12937162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.
    Masson D; Koseki M; Ishibashi M; Larson CJ; Miller SG; King BD; Tall AR
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2054-60. PubMed ID: 19815817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
    Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ
    Biochim Biophys Acta; 2012 Mar; 1821(3):502-12. PubMed ID: 21944998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
    Parks BW; Srivastava R; Yu S; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
    Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
    J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice.
    Averill MM; Kim EJ; Goodspeed L; Wang S; Subramanian S; Den Hartigh LJ; Tang C; Ding Y; Reardon CA; Getz GS; Chait A
    PLoS One; 2014; 9(10):e109252. PubMed ID: 25286043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.
    Pollard RD; Blesso CN; Zabalawi M; Fulp B; Gerelus M; Zhu X; Lyons EW; Nuradin N; Francone OL; Li XA; Sahoo D; Thomas MJ; Sorci-Thomas MG
    J Biol Chem; 2015 Jun; 290(25):15496-15511. PubMed ID: 25947382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.
    Morishima A; Ohkubo N; Maeda N; Miki T; Mitsuda N
    J Biol Chem; 2003 Oct; 278(40):38188-93. PubMed ID: 12882972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of expression of apolipoprotein A-I by selenium status in human liver hepatoblastoma cells.
    Stahle JA; Vunta H; Channa Reddy C; Sandeep Prabhu K
    Eur J Nutr; 2009 Aug; 48(5):283-90. PubMed ID: 19294445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice.
    Sui Y; Park SH; Helsley RN; Sunkara M; Gonzalez FJ; Morris AJ; Zhou C
    J Am Heart Assoc; 2014 Apr; 3(2):e000492. PubMed ID: 24755147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of TNFalpha on activities of different promoters of human apolipoprotein A-I gene.
    Orlov SV; Mogilenko DA; Shavva VS; Dizhe EB; Ignatovich IA; Perevozchikov AP
    Biochem Biophys Res Commun; 2010 Jul; 398(2):224-30. PubMed ID: 20599735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice.
    Wang X; Chen Q; Pu H; Wei Q; Duan M; Zhang C; Jiang T; Shou X; Zhang J; Yang Y
    Lipids Health Dis; 2016 Feb; 15():33. PubMed ID: 26965176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.